Type C: Thrombi
are rare, share and similar appearance to a myxoma and are highly mobile.
We attribute this patient's rapidly evolving four-chamber intracardiac thrombi
to his underlying ATTRwt amyloid cardiomyopathy and concomitant systolic dysfunction.
However few reports have been documented regarding treatment of mobile aortic thrombi
with endovascular stent graft [21-26].
Lesions removed from the SMV have been reported to be tumor thrombi
(T4N2M1) (Figure 5).
In Pakistan, free floating thrombi
remain largely under diagnosed and are likely mistaken for intracardiac structures.
Identification of SVS may help guide therapeutic decisions in terms of indicating whether an occlusive clot is susceptible or resistant to fibrinolytic therapy,, as stated, old, platelet-rich and well-organized thrombi
formed under flow conditions have been shown to be more resistant to thrombolysis than fresh, fibrin- and red cell-rich clots formed under conditions of stasis, and it is essential to identify the clot composition and time phase; therefore, we can treat different individuals with the most suitable therapy based on clot characteristics.
Left ventricular thrombi
in association with normal left ventricular wall motion in patients with malignancy.
Higher mortality has been reported in patients with left ventricular thrombi
after infarction, especially when these develop within the first 48 h after infarction17.
The differential diagnosis of RA masses includes benign or malignant primary or metastatic tumors, tricuspid valve vegetations, and thrombi
. Sometimes, RA thrombi
are in transit, having migrated from the venous system to the heart; this is likely the case with the large tubular thrombus we describe in this case.
A cardiac MRI revealed multiple right atrial thrombi
Mott, "Intracardiac thrombi
in pediatric patients: presentation profiles and clinical outcomes," Pediatric Cardiology, vol.
There were two modes of rtPA administration: either it was administered only into a multihole catheter placed in the popliteal artery or the dose was divided into a kink resistant sheath and into a distally placed catheter, so that the thrombolytic solution would be infused at two points into the arterial system, depending on the localization of residual thrombi
. The angiographic effect was usually checked within 10-20 hours.